Improving asthma care for children and young people Considerations for pharmacists in helping young patients manage their asthma.…
How to approach challenging scenarios in primary care pharmacy Three examples of vulnerable patients and those at risk of harm. The featured scenarios consider themes of suicide, addiction and sexual violence.…
‘Blanket switch’ to greener inhalers not recommended in prescribing guidance The Scottish government has published a consultation on draft guidance emphasising that patients should only be switched to greener inhalers “if effectiveness, safety or adherence is not compromised”.…
Government funding to help UK development of greener inhalers Kindeva Drug Delivery said it is aiming to manufacture inhalers with new propellants that have 90% lower global warming potential than the current greenest option used in the industry.…
Regulator approves first RSV vaccine for older adults Data suggest that respiratory syncytial virus accounts for 8,000 deaths each year in adults aged 60 years and over in the UK.…
Children and young people with asthma: pharmacological management and monitoring The second of our two-part series on asthma in children and young people outlines pharmacological management and appropriate monitoring of the condition.…
Children and young people with asthma: symptoms, diagnosis and the role of pharmacy The first of our two-part series on asthma in children and young people is an overview of the condition, outlining the role pharmacy can play in supporting patients and their families and/or carers.…
Asthma inhaler recycling will not be renewed, manufacturer confirms A pilot scheme that led to more than 52,000 inhalers being recycled will not be renewed, manufacturer Chiesi has said.…
Monoclonal antibody found to improve COPD outcomes, trial results suggest The monoclonal antibody treatment dupilumab was found to reduce the annual rate of moderate or severe exacerbations of chronic obstructive pulmonary disease when compared with placebo.…
Cystic fibrosis: management and monitoring of respiratory manifestations An overview of the pharmacological management of respiratory symptoms in people with cystic fibrosis to ensure they can optimise benefit from their medication regime.…
